Pilot study of the effectiveness of the anaplerotic medication Triheptanoin in improving muscle strength in patients with sporadic Inclusion Body Myositis
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Triheptanoin (Primary)
- Indications Inclusion body myositis
- Focus Therapeutic Use
- Sponsors Ultragenyx Pharmaceutical
Most Recent Events
- 04 Mar 2014 New trial record